Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EXAS | ROIV | INCY | ||
| Company | Exact Sciences Cor | Roivant Sciences Ltd | Incyte Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 104.93 | 28.36 | 98.60 | ||
| High | 104.98 | 28.90 | 99.87 | ||
| Low | 104.90 | 28.17 | 97.47 | ||
| Latest | 104.91 | 28.56 | 98.56 | ||
| Change | +0.99 | +0.28 | +0.79 | ||
| % Change | +0.95% | +0.99% | +0.81% | ||
| Volume | 21,562,100 | 5,604,900 | 877,800 | ||
| 20-Day Average Volume | 3,124,595 | 4,920,910 | 1,414,225 | ||
| Previous Close | 103.92 | 28.28 | 97.77 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 103.57 | 28.57 | 96.95 | ||
| 20-Day Raw Stochastic | 96.55% | 48.08% | 57.33% | ||
| 20-Day Relative Strength | 75.93 | 52.93 | 53.66 | ||
| Weighted Alpha | +85.47 | +160.16 | +51.94 | ||
| Today's Opinion | 100% Buy | 80% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 64% Buy | 24% Buy | ||
| Last Month's Opinion | 100% Buy | 96% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.29% since 03/13/26 | +2.62% since 05/01/26 | +1.70% since 05/01/26 | ||
| Low | 103.60 on 03/16/26 | 27.52 on 05/04/26 | 96.15 on 05/05/26 | ||
| High | 104.98 on 03/20/26 | 29.00 on 05/05/26 | 100.01 on 05/06/26 | ||
| 1-Month | |||||
| %Chg | +1.43% since 02/20/26 | +1.38% since 04/08/26 | +2.78% since 04/08/26 | ||
| Low | 102.95 on 02/27/26 | 27.06 on 04/24/26 | 92.79 on 04/28/26 | ||
| High | 104.98 on 03/20/26 | 30.18 on 04/17/26 | 102.86 on 04/29/26 | ||
| 3-Month | |||||
| %Chg | +3.03% since 12/19/25 | +10.61% since 02/06/26 | -9.07% since 02/06/26 | ||
| Low | 101.44 on 12/23/25 | 25.72 on 02/09/26 | 89.25 on 03/24/26 | ||
| High | 104.98 on 03/20/26 | 30.33 on 03/11/26 | 109.48 on 02/09/26 | ||
| 6-Month | |||||
| %Chg | +96.76% since 09/19/25 | +38.51% since 11/07/25 | -7.00% since 11/07/25 | ||
| Low | 51.75 on 09/24/25 | 19.79 on 11/10/25 | 89.25 on 03/24/26 | ||
| High | 104.98 on 03/20/26 | 30.33 on 03/11/26 | 112.29 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 20,026,062 | 20,440,420 | 19,690,512 | ||
| Shares Outstanding, K | 190,888 | 715,701 | 199,782 | ||
| Annual Sales | 3,246,990,000 | 29,050,000 | 5,141,240,000 | ||
| Annual Net Income | -207,950,000 | -171,980,000 | 1,286,650,000 | ||
| Last Quarter Sales | 878,380,000 | 2,000,000 | 1,272,680,000 | ||
| Last Quarter Net Income | -85,960,000 | -265,890,000 | 303,330,000 | ||
| 60-Month Beta | 1.41 | 1.14 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 02/13/26 | -0.24 on 02/06/26 | 1.81 on 04/28/26 | ||
| Earnings Date | 05/07/26 | 06/04/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 2,598.00 | 0.00 | 15.16 | ||